Skip to main content
. 2018 Jan 25;62(2):e02217-17. doi: 10.1128/AAC.02217-17

FIG 2.

FIG 2

Combinations of baseline substitutions across NS3 and NS5A in GT1b-infected DAA-experienced patients. Shown are the numbers and percentages of patients with baseline substitutions in NS3 (position 168) in combination with NS5A substitutions at position 31, 32, or 93 or at other positions (positions 24, 28, 30, 58, and 92) detected by NGS at a ≥15% prevalence within a patient's viral population.